SB Drug Discovery
David Dalrymple has extensive experience in business development within the biomedical sector, currently serving as Director of Business Development at SB Drug Discovery since March 2012. Prior to this role, David held the position of Business Development Manager at Scottish Biomedical from February 2010 to March 2012, and worked as a Territory Manager at Clontech - Takara Bio Europe from 2007 to 2010. David holds a degree from the University of Glasgow.
This person is not in the org chart
This person is not in any teams
SB Drug Discovery
SB Drug Discovery (part of Sygnature Discovery) is an industry leader in specialist contract research, providing critical data for novel drug development through cell line generation, assay development and compound screening services. With a global reputation for outstanding customer service, our clients know their research is in the best hands. Using the latest technologies, our expert teams deliver fast, reliable and robust data customized to meet our clients' requirements and are on-hand to discuss options at every stage. Together, we are driving the discovery of tomorrow's novel therapeutics - today.